Sigma Healthcare (ASX:SIG) said its Chemist Warehouse unit reported preliminary unaudited total retail network sales of AU$5.15 billion in the fiscal half ended December 2024, compared with AU$4.56 billion a year earlier, according to a Tuesday filing with the Australian bourse.
The pharmacy's preliminary unaudited total like-for-like retail network sales grew 10.3% compared with an 8.9% growth the previous year, driven by a strong trading performance in December 2024, the filing said.
Shares of Sigma Healthcare rose 8% in recent Tuesday trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。